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ABSTRACT 
 
T-cell immunoglobulin and mucin domain (TIM)-3 have been shown to negatively regulate 
Th1 cell-mediated immunity. Activation of TIM-3 by galectin-9 induces Th1 cell apoptosis, 
which may contribute to skewing of immune response towards Th2-dominant immunity. The 
aim of this study was to determine whether certain genetic variations of TIM-3 influence 
predisposition to asthma in a sample of Iranian population. 
This case-control study was conducted on 209 patients with asthma and 200 healthy 
controls. The +4259 T>G and -574 G>T polymorphisms were detected using polymerase 
chain reaction-restriction fragment length polymorphism (PCR-RFLP) and amplification 
refractory mutation system-PCR (ARMS-PCR). Total serum IgE was further measured with 
ELISA. 
Notably, +4259T > G and-574G>T polymorphisms of TIM-3 were significantly associated 
with the susceptibility to asthma. In addition, the present study showed a significant difference 
between the distribution frequency of the GT + TT genotype and T allele on the +4259 T>G 
and -574 G>T locus between the groups. However, no correlation between the +4259 T > G 
and -574G > T polymorphisms and total serum IgE levels were observed. 
Together these results suggest that the TIM-3 +4259 T>G and -574 G>T polymorphisms 
are greatly associated with the susceptibility of Iranian population to asthma, which could open 
up new horizons for  better understanding of the pathophysiology, diagnostic, prognostic and 
therapeutic approaches of asthma.  
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INTRODUCTION 
 
Asthma is a serious chronic airway inflammatory 
disease caused by a combination of genetic and 
environmental factors affecting 300 million people 
worldwide.
1-3
 Due to worldwide rise in its prevalence, 
extensive genome-wide association studies as well as 
more targeted searches for speciﬁc genes have been 
used to discover common genetic variations associated 
with asthma.
4
 
The T cell immunoglobulin and mucin domain-
containing molecules (TIMs) are type 1 transmembrane 
proteins expressed on various immune cells. 
 Three functional TIM genes have been identified 
so far in the human genome including TIM-1, TIM-3 
and TIM-4.
5,6
 TIM gene family  located in chromosome 
5q33.2 and have been shown to play an important role 
as a human susceptibility gene for several 
inflammatory diseases such as asthma, allergy and 
autoimmunity disease by regulating Th1 and Th2-cell-
mediated immunity. All of the TIM molecules encode 
type 1 cell-surface glycoproteins with common 
structural motifs including signal peptides, 
immunoglobulin variable region-like domains, mucin-
like domains, transmembrane regions, and intracellular 
tails.
7
  
Among different members, TIM-3 has been 
reported to be expressed at the highest level on Th1 
cells but not on Th2 cells. Interaction of TIM-3 with its 
main ligand, C-type lectin, galectin-9 (Gal9), has been 
shown to promote the apoptosis of Th1 cells. Thus, 
TIM-3 is a negative regulatory molecule important for 
Th1-mediated immune responses and TIM3/Gal9 
interaction may ameliorate autoimmune diseases and 
asthma by indirectly modulating the balance between 
Th1 and Th2 type responses.
8-10
 
 The polymorphisms of TIM-3 has been associated 
with the susceptibility of human to Th2-mediated 
allergic diseases since it affects the Th1/Th2 balance 
and skew the immune response towards Th2-dominant 
immunity.
11,12
 However, it has not yet been clearly 
determined whether the variations within the coding or 
non-coding regions of TIM-3 are involved in the 
protein expression, stability or function of this 
protein.
13
 
Previous investigations demonstrated the effect of 
different polymorphisms on allergic diseases in 
different populations. As none of the TIM-3 
polymorphisms have yet been evaluated in Iranian 
patients with asthma; in the current study, we aimed to 
analyze the association of -574G>T and + 4259T>G 
polymorphisms of TIM-3 in asthma patients and non-
atopic controls. We also assessed the relationship 
between these polymorphisms and serum IgE levels in 
asthmatic patients. This study may open up new 
horizons for better understanding of the 
pathophysiology, diagnostic, prognostic and therapeutic 
approaches of asthma. 
 
MATERIALS AND METHODS 
 
Subjects 
This hospital-based case-control study included a 
total of 209 patients with confirmed asthma and 200 
healthy controls. The 209 asthmatic patients had 
symptoms such as coughing, wheezing, episodic 
breathlessness as well as chest tightness, and were 
diagnosed according to the global initiative for asthma 
guidelines (GINA). Participants of the current study 
were recruited between October 2014 to May 2015 at 
the Amin hospital, Isfahan, Iran. Healthy individuals 
(n= 200) were selected from general population based 
on comprehensive medical screening at Amin hospital. 
All controls were examined for asthma and a family 
history of asthma; and did not have any symptoms of 
allergic and respiratory diseases in their history or past 
physical check-up. Current pregnancy or breast-feeding 
as well as presence of parasitic infection were 
exclusion criteria for both groups. 
All subjects participated voluntarily in this study 
and signed written informed consent. Experimental 
protocols of this study were approved by the Isfahan 
University of Medical Sciences Ethic Committee (No. 
392448) and were performed in compliance with the 
provisions of the Declaration of Helsinki.  
 
DNA extraction 
Peripheral blood specimens were collected from all 
subjects in vacuum tubes containing 
ethylenediaminetetraacetic acid (EDTA). Genomic 
DNA was extracted from white blood cells of each 
samples using a genomic DNA extraction kit 
(Genotbio, Korea) according to the manufacturer’s 
instructions. DNA concentration and purity were 
determined using a nucleic acid spectrometer (Bio-Rad, 
CA, USA). DNA samples with A260/280 ratio with 
expected values from 1.8 to 2.0 were used for 
polymerase chain reaction (PCR) templates. 
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Serum concentrations of total IgE 
Total serum IgE level was measured with human 
IgE ELISA kit (Euroimmun, Germany) according to 
manufacturer’s instruction.   
 
TIM3 -574 G>T genotyping 
The -574 G>T polymorphism was genotyped  
by amplification refractory mutation system (ARMS-
PCR) analysis. Two reactions were performed;  
each containing a common reverse primer  
(R1 5'-GGTGTCTGATTGCCAGTGATTC-3')  
and one allele-specific primer (F1:5'-
GGCTTATGCTGGGAGTTGCT -3' or F2 5'-
GGCTTATGCTGGGAGTTGCG -3'). 
F1 and R1 were used to amplify T allele fragments, 
and F2 and R1 were used to amplify G allele 
fragments; all the amplified fragments were499 base 
pair PCR with F1/R1 and F2/R1. 
The reaction mixture included 2.5 µL 10× PCR 
buffer, 0.5 μL dNTP; 1 µL forward primer; 1 µL reverse 
primer, 0.6 µL Mgcl2; 2 µL DNA templates, 0.5 µL Taq 
DNA polymerase. The final volume of the mixture was 
made up to 25 μL with double distilled water. 
The reaction was performed with a Thermo Cycler 
(Eppendorf, Germany) in 95°C for 2 min, followed by 
35 cycle of 94°C for 30 s, 64.6°C for 30 s, 72°C for 1 
min, and a final extension at 72°C for 10 min. Next, 5 
μL of the amplified products was used for 1.5% 
agarose gel electrophoresis. The PCR products were 
visualized by ethidium bromide (EB) staining.  
 
TIM-3 +4259T>G genotyping 
The TIM-3 4259T>G polymorphism was genotyped 
using the polymerase chain reaction-restriction 
fragment length polymorphism (PCR-RFLP) method. 
The primer sequences and restriction enzyme are 
shown in Table 1. 
Mixes containing 2 ng of genomic DNA, 1 µL of 
each primer, 0.6 µL of Taq DNA polymerase, 2.5 µL 
10x buffer, 0.9 µL Mgcl2, 0.6 µL dNTP and double 
distilled water was further added to reach the final 
volume. The reaction mixture was heated in a Thermo 
Cycler (Eppendorf, Germany) to amplify the target 
amplicons. The PCR cycle parameters were as follows: 
general denaturation at 94°C for 5 min, 1 cycle, 
followed by 35 cycles of 94°C for 30 s, annealing at 
55°C for 30 s, and extension at 72°C for 1 min 
followed by a final extension at 72°C for 10 min. DNA 
digestion condition was as follows: 1 units of PST 1, 
2X buffer and 10 µL PCR product. The final volume 
was made up to 20 μL with double distilled water. The 
samples were incubated at 37° for 90 min with 
restriction enzyme. This enzyme digests the 649 bp 
PCR products into 474 and 175 fragments when the G 
allele is presented. Digested fragments were separated 
on 8% polyacrylamide gel electrophoresis (PAGE) at 
100 V for 3 h and were visualized by silver nitrate 
staining. 
 
Statistical Analysis 
Statistical analyses were performed using SPSS 
20.0 software package (IBM Corp Armonk, NY, USA). 
Genotype and allele frequencies were analyzed using 
chi square test. Odds ratios (OR), p value and 95% 
confidence interval (CI) were also calculated. Results 
were considered statistically significant when p< 0.05. 
 
RESULTS 
 
Characteristics of the Study Population 
The characteristics of the study population recruited 
to groups of patients with asthma (n=209) and the 
controls (n=200) are summarized in Table 2. As it is 
shown in Table 2, there were no significant variations 
in mean and distribution of age and sex between the 
groups (p=0.399 and p=0.142, respectively). Patients 
with asthma showed higher level of total serum IgE 
compared to the control group) p=0.001(. In addition, 
smoking status was checked and no significant 
difference was observed between case and control 
groups (p=0.726). 
We further evaluated TIM-3 -574 G>T and +4259 
T>G genotypes distributions of both groups of patients 
with asthma (n=209) and the controls (n=200) (Table 
3) and found significant differences in genotype and 
allele frequencies between 2 groups (p=0.000 and 
p=0.001, respectively). 
 
Genotype and Allele analyses of the -574 G>T 
Polymorphism 
At this position, G and T allele were defined as wild-
type and mutant alleles, respectively. After agarose gel 
electrophoresis, the GG genotypes were characterized 
as wild GG homozygotes, TT genotypes as mutant TT 
homozygotes and GT genotypes as GT heterozygotes. 
In the present study, 180 asthmatic patients had the GG 
genotype, and other asthmatic patients had the GT 
genotype. However, GG genotype was found in 196 
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Table 1. Primer sequence, restriction enzyme, alleles and fragment sizes of the region containing 4259 T>G polymorphism 
Polymorphism Primer sequence 5´→ 3´ Restriction enzyme Alleles Fragment sizes 
4259 T>G F: GGGAAGGTGATGGGCTTT 
R: GGCAGGTTTGGAAGCTGA 
PstІ 
G 
T 
474;174 
474;159.16 
 
 
Table 2. Clinical and demographic characteristics of patients and controls evaluated for association between +4259 T>G and 
-574 G>T polymorphisms of TIM-3 with asthma in an Iranian population  
 Patients(n=209 ) Control (n =201) p value 
Age (mean ± SD) 43.167±14.89 41.96±14.11 0.399 
Gender 
  Male/Female 
 
69/140 
 
81/120 
 
0.142 
Total serum IgE log10 (mean ± SD) 1.74±0.65 0.75±0.38 0.001 
Smoking 
   No /Yes 
 
202/7 
 
193/8 
 
0.726 
 
 
Table 3. Genotype and allele analyses of the -574 G>Tand +4259 G>T  polymorphisms among controls and patients with 
asthma 
 
 
Genotype/Allele 
 
Asthma group 
(n=209),n(%) 
Control group 
(n=200), n (%) 
Odds 
ratio 
95% CI p value 
-574G>T GT+TT 29+0 (13.87) 4+0 (1.99) 7.935 (2.73, 3.011) 0.000 
GG 180 (86.12) 197 (98) 
T 29 4 7.418 (2.58, 21.29) 0.000 
G 389 398 
+4259G>T GT+GG 69+0 (33.01) 37+0 (18.40) 2.185 (1.38 ,3.45) 0.001 
TT 140 (66.98) 164 (81.59) 
G 69 37  
1.95 
(1.27, 2.98) 0.002 
T 349 365 
 
 
control subjects, while only 4 subjects had the GT 
genotype. TT genotype was identified neither in 
patients with asthma nor in the control subjects (Figure 
1). In the asthma group, at the -574 G>T position on 
TIM-3, the genotype frequencies for GG and GT were 
86.12 and 13.87%, respectively. In the control group, 
98.01% of the subjects had the GG genotype, and the 
remaining 1.99% had the GT genotype. Differences of 
the genotype frequencies between 2 groups were 
statistically significant (Table 3). 
 
Genotype and Allele Analyses of the +4259 T>G 
Polymorphism 
At the +4259 T>G position, the genetic 
polymorphism was demonstrated as 2 genotypes (GT 
and TT). Because PCR products of the GG genotype 
make a recognition site of PstI endonuclease; after 
digestion, they could be cleaved into 2 DNA fragments 
known as 474 bp and 174bp. Alternation of this 
position (from T to G) disrupts the recognition site of 
PstI endonuclease and the PCR products of the TT 
genotype have 474, 159 and 16 bp fragments, while the 
PCR products of GT genotype could be split into 4 
DNA fragments including 474, 174, 159 and 16 bp 
(Figure 2).  
Unfortunately, due to their low molecular weight, 
the 16 bp DNA fragments could not be visualized by 
agarose gel electrophoresis. Here, 140 patients had the 
TT genotype, and the other patients (n=69) had the GT 
genotype; meanwhile, in the control group, 164 had the 
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TT genotype and 37 had the GT genotype. 
In the asthma group, at +4259 G>T position on 
TIM-3, the TT and GT genotypes had frequencies of 
66.9% and 33.0%, respectively. In contrast, 81.5% of 
the control subjects had the TT genotype, and the other 
18.4% had the GT genotype. There was significant 
statistical difference between these 2 groups (Table 3). 
We further investigated the relationship between  
the genotypes of each polymorphic site of TIM-3 with 
total serum IgE levels in asthmatic patients. These two 
polymorphisms of TIM-3 in asthma patients were 
showed to have no significant association with the 
levels of IgE (Table 4). 
 
 
 
 
Figure 1. Genotype analyzed by ARMS-PCR method for the -574G>T. M: represents for 50 bp DNA marker; 1 and 2 
represents genotype of GT; 3 represents genotype of GG. [F1 amplify mutant allele and F2 amplify normal allele]. The TT 
genotype was not identified in the patients with asthma or in the control subjects. 
 
 
Figure 2. Genotype analyzed by PCR-RFLP method for the+4259G>T polymorphism of the TIM-3 gene. The PCR amplified 
products were digested with PstI: Electrophoretogram of +4259 G>T TIM-3 gene. M represents 50 bp DNA size marker; 1 
and 3 represent genotype of GT; 2, 4-6 represents genotype of TT. Number 7 represents PCR product. 
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Table 4. Association between total serum immunoglobulin (Ig) E levels and TIM-3 -574 G>T and TIM-3 +4256 G>T 
polymorphisms in patients with asthma 
p.value Total serum IgE (log10 value) Genotype  
> 0.05 1.619 ± 0.606 GG -574G>T 
> 0.05 1.730 ± 0.647 GT 
> 0.05 1.579   0.608 TT +4259G>T 
> 0.05 2.05   0.652 GT 
TIM-3: T cell immunoglobulin and mucin domain 3 
 
 
DISCUSSION 
 
Asthma is a heterogeneous chronic inflammatory 
disorder characterized by episodes of reversible airway 
narrowing, bronchial hyperresponsiveness and airway 
remodeling.
14
 The pathophysiology of asthma is 
complex with both genetic as well as environmental 
risk factors and involves both innate and adaptive 
immune responses, various inflammatory cells, 
cytokines and pattern recognition receptors. Upon 
inhalation of an allergen, antigen presenting cells in the 
airway migrate to the draining lymph nodes where they 
present the antigen to precursor T-helper cells. 
Precursor T-helper cells then maturate and differentiate 
into Th2  cells leading to the production and activation 
of eosinophils, the release of cytokines such as IL-4 
and IL-13, activation of B cells and subsequent of IgE-
producing plasma cells.
15-19
 
It has been speculated that genes that are involved 
in the regulation of Th1/Th2 balance could be 
potentially considered as asthma predisposing factors. 
TIM-3, as an example, is known to negatively regulate 
the Th1 cell-mediated immunity and it is located on 
human chromosome 5q33; a region that has been 
reported to be associated with asthma susceptibility. 
TIM-3 is highly expressed on terminally differentiated 
Th1 cells but not on Th2 cells it is therefore identified 
as a Th1-specific marker. TIM-3 binds to its ligand, 
Gal9, and TIM3-Gal9 interaction induces Th1 
apoptosis and downregulates Th1 responses. 
Subsequently, it shifts the immune response towards 
Th2-dominant immunity.
20,21
  
In the present study, the frequency of two 
polymorphisms at TIM-3 gene promoter and coding 
region (-574 G>T and +4259 T>G, respectively) in an 
Iranian population with asthma was investigated. 
The current study demonstrated that the frequencies 
of GG, GT and TT genotypes in -574 G>T 
polymorphism in the TIM-3 promoter region were 
86.12, 13.87 and 0%, respectively in the asthma 
population, while these frequencies were 0.98.01, 1.99 
and 0%, respectively in the healthy population. Hence, 
our findings indicated that the T allele in -574 G>T 
polymorphism is a risk factor for asthma susceptibility. 
The role of TIM-3 promotor polymorphisms in 
allergic phenotypes has been investigated in a number 
of studies. Chae et al. investigated the frequency of -
574 G>T TIM-3 polymorphism in asthma and allergic 
rhinitis in patients from a Korean population. They 
showed that −574 T allele was found only in asthma 
and rhinitis patients at the frequency of 1% and 1.5%, 
respectively, while all healthy controls carried the G 
allele. Although, this polymorphism was associated 
with symptoms of allergic asthma or rhinitis, a 
significant correlation was observed neither with serum 
IgE level nor with blood eosinophil counts, which was 
in agreement with our study.
12
  
In Zhang et al. study, polymorphisms of TIM-3 in 
promotor region (574 G/T , -882 C/T , -1516 G/T , -
1571delC, -1766G/T and -1922 G/A) was not 
associated with asthma or related phenotype. 
(22) 
Also 
In Caucasian and African-American populations no 
association was seen between TIM3 polymorphisms 
with any phenotype.
23,24 
Study conducted by Graves et 
al. reported a positive correlation between atopic 
diseases in children from white or Hispanic parents and  
882 C>T polymorphism in promoter region of TIM-3. 
In addition, −882 C>T polymorphism has been shown 
to be associated with atopic dermatitis.
25
  
Therefore, such polymorphisms in promoter region 
of TIM-3 might positively affect its expression which 
in turn elevates Th2 responses. 
In the present study, the frequencies of TT, GT and 
GG genotypes of +4259 T>G polymorphism were 
66.98, 33.01, 0% and 81.5, 18.4 and 0% in the 
asthmatic and healthy population, respectively. The GT 
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genotype and G allele frequencies of +4259 T>G 
polymorphism between asthma patients and controls 
were significantly different; therefore, it could be 
speculated that the polymorphism of +4259 T>G may 
contribute to the asthma pathogenesis.  
Contrary findings have been reported in different 
studies, which looked into possible correlation between 
+4259 T>G polymorphism and asthma. In the Study 
conducted by Chae et al on Korean population, the 
minor T allele of +4259 T>G was found more 
frequently in rhinitis patients, but not in asthma 
patients. However, in another study performed on 
children from white or Hispanic parents, neither atopic 
dermatitis nor asthma was associated with +4259 T>G 
polymorphism.
12
 This discrepancy may be due to the 
different ethnic and regional group studied in these 
reports. 
Linkage between IgE phenotypes and chromosome 
5q have been previously evidenced.
26
 In the present 
study, we investigated the relationship between these 
single nucleotide polymorphism (SNPs) of TIM-3 with 
total serum IgE levels in asthma patients. In the current 
study, no significant association between serum IgE 
levels and polymorphisms of TIM-3 were observed in 
asthma patients. This finding was in a line with the 
study of Chaee et al., who did not find an association 
between TIM-3 polymorphisms and total serum IgE 
levels in a Korean population.
12
  
In conclusion, we demonstrated that TIM-3 -574 
G>T and 4259 T>G polymorphisms may play an 
important role as genetic risk factors in the 
immunopathophysiology of asthma. However, it has 
not been yet investigated whether variations within the 
coding or non-coding regions of TIM-3 lead to 
increased TIM-3 protein expression, stability or its 
function. It is also important to find out whether or not 
these polymorphisms are replicable in other 
populations and to examine the roles of associated 
variants in TIM-3 expression and function. It would 
also be interesting to analyze the allele frequency of 
these polymorphisms with larger sample size in 
patients with autoimmune and allergic diseases. 
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